Heart-type fatty acid binding protein is an early marker of myocardial damage after radiofrequency catheter ablation

Clinical Biochemistry

Volumn 43, Issue 15, 2010, Pages 1241-1245

  Giannessi, Daniela ^a   Piacenti, Marcello ^a   Maltinti, Maristella ^b   Rossi, Andrea ^b   Di Cecco, Pietro ^b   Startari, Umberto ^b   Cabiati, Manuela ^c   Panchetti, Luca ^b   Del Ry, Silvia ^a   Morales, Maria Aurora ^a  

^a INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

^b Fondazione Toscana G Monasterio   (Italy)

^c SCUOLA SUPERIORE SANT ANNA   (Italy)

Author keywords

Atrial ablation; Biomarkers; CK MBmass; CTnI; H FABP; Myocardial injury; Myoglobin; RF ablation; Tachyarrhythmia; Ventricular ablation

Indexed keywords

CREATINE KINASE MB; FATTY ACID BINDING PROTEIN; MYOGLOBIN; TROPONIN I;

ADULT; AGED; ARTICLE; CATHETER ABLATION; CLINICAL ARTICLE; DISEASE MARKER; FEMALE; HEART MUSCLE INJURY; HEART VENTRICLE TACHYCARDIA; HUMAN; MALE; PRIORITY JOURNAL; SUPRAVENTRICULAR TACHYCARDIA;

ADULT; AGED; BIOLOGICAL MARKERS; CATHETER ABLATION; FATTY ACID-BINDING PROTEINS; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIUM; REFERENCE VALUES; REGRESSION ANALYSIS; TIME FACTORS;

EID: 77956781918     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2010.08.003     Document Type: Article

References (31)

1. Manolis A.S., Wang P.J., Estes N.A. Radiofrequency catheter ablation for cardiac tachyarrhythmias. Ann Intern Med 1994, 121:452-461.
2. Morady F. Radio-frequency ablation as treatment for cardiac arrhythmias. N Engl J Med 1999, 340:534-544.
3. Calkins H. Catheter ablation for cardiac arrhythmias. Med Clin North Am 2001, 85:473-502.
4. Bogun F., Crawford T., Reich S., Koelling T.M., Armstrong W., Good E., Jongnarangsin K., Marine J.E., Chugh A., Pelosi F., Oral H., Morady F. Radiofrequency ablation of frequent, idiopathic premature ventricular complexes: comparison with a control group without intervention. Heart Rhythm 2007, 4:863-867.
5. Spector P., Reynolds M.R., Calkins H., Sondhi M., Xu Y., Martin A., Williams C.J., Sledge I. Meta-analysis of ablation of atrial flutter and supraventricular tachycardia. Am J Cardiol 2009, 104:671-677.
6. Nath S., DiMarco J.P., Haines D.E. Basic aspects of radiofrequency catheter ablation. J Cardiovasc Electrophysiol 1994, 10(5):863-876.
7. Emkanjoo Z., Mottadayen M., Givtaj N., Alasti M., Arya A., Haghjoo M., Fazelifar A.F., Alizadeh A., Sadr-Ameli M.A. Evaluation of post-radiofrequency myocardial injury by measuring cardiac troponin I levels. Int J Cardiol 2007, 117:173-177.
8. Manolis A.S., Vassilikos V., Maounis T., Melita-Manolis H., Psarros L., Haliasos A., Cokkinos D.V. Detection of myocardial injury during radiofrequency catheter ablation by measuring serum cardiac troponin I levels: procedural correlates. J Am Coll Cardiol 1999, 34:1099-1105.
9. Katritsis D., Hossein-Nia M., Anastasakis A., Poloniecki I., Holt D.W., Camm A.J., Ward D.E., Rowland E. Use of troponin-T concentration and kinase isoforms for quantitation of myocardial injury induced by radiofrequency catheter ablation. Eur Heart J 1997, 18:1007-1013.
10. Haines D.E., Whayne J.G., Walker J., Nath S., Bruns D.E. The effect of radiofrequency catheter ablation on myocardial creatine kinase activity. J Cardiovasc Electrophysiol 1995, 6:79-88.
11. McCann C.J., Glover B.M., Menown I.B., Moore M.J., McEneny J., Owens C.G., Smith B., Sharpe P.C., Young I.S., Adgey J.A. Investigation of a multimarker approach to the initial assessment of patients with acute chest pain. Adv Ther 2009, 26:531-534.
12. Okamoto F., Sohmiya K., Ohkaru Y., Kawamura K., Asayama K., Kimura H., Nishimura S., Ishii H., Sunahara N., Tanaka T. Human heart-type cytoplasmic fatty acid-binding protein (h-FABP) for the diagnosis of acute myocardial infarction. Clinical evaluation of H-FABP in comparison with myoglobin and creatine kinase isoenzyme MB. Clin Chem Lab Med 2000, 38:231-238.
13. Bertinchant J.P., Polge A. Diagnostic and prognostic value of heart type fatty acid-binding protein (h-FABP), an early biochemical marker of myocardial injury. Arch Mal Couer Vaiss 2005, 98:1225-1231.
14. Seino Y., Ogata K., Takano T., Ishii J., Hishida H., Morita H., Takeshita H., Takagi Y., Sugiyama H., Tanaka T., Kitaura Y. Use of a whole blood rapid panel test for heart-type fatty acid-binding protein in patients with acute chest pain: comparison with rapid troponin T and myoglobin tests. Am J Med 2003, 115:185-190.
15. Li C.J., Li J.Q., Liang X.F., Li X.X., Cui J.G., Yang Z.J., Guo Q., Cao K.J., Huang J. Point-of-care test of heart-type fatty acid-binding protein for the diagnosis of early acute myocardial infarction. Acta Pharmacol Sin 2010, 31:307-312.
16. Figiel Ł., Kasprzak J.D., Peruga J., Lipiec P., Drozdz J., Krzemińska-Pakuła M., Smigielski J. Heart-type fatty acid binding protein-a reliable marker of myocardial necrosis in a heterogeneous group of patients with acute coronary syndrome without persistent ST elevation. Kardiol Pol 2008, 66:253-259.
17. Pilo A., Zucchelli G.C., Malvano R., Masini S. Main features of computer algorithms for RIA data deduction; comparison of some different approaches for the interpolation of the dose-response curve. J Nucl Med Allied Sci 1982, 26:235-248.
18. Kleine A.H., Glatz J.F., Van Nieuwenhoven F.A., Van der Vusse G.J. Release of heart fatty acid-binding protein into plasma after acute myocardial infarction in man. Mol Cell Biochem 1992, 116:155-162.
19. Glatz J.F., van der Vusse G.J., Simoons M.L., Kragten J.A., van Dieijen-Visser M.P., Hermens W.T. Fatty acid-binding protein and the early detection of acute myocardial infarction. Clin Chim Acta 1998, 272:87-92.
20. Chan C.P., Sanderson J.E., Glatz J.F., Cheng W.S., Hempel A., Renneberg R. A superior early myocardial infarction marker. Human heart-type fatty acid-binding protein. Z Kardiol 2004, 93:388-397.
21. Ruzgar O., Bilge A.K., Bugra Z., Umman S., Yilmaz E., Ozben B., Umman B., Meric M. The use of human heart-type fatty acid-binding protein as an early diagnostic biochemical marker of myocardial necrosis in patients with acute coronary syndrome, and its comparison with troponin-T and creatine kinase-myocardial band. Heart Vessels 2006, 5:309-314.
22. Van Nieuwenhoven F.A., Kleine A.H., Wodzig W.H., Hermens W.T., Kragten H.A., Maessen J.G., Punt C.D., Van Dieijen M.P., Van der Vusse G.J., Glatz J.F. Discrimination between myocardial and skeletal muscle injury by assessment of the plasma ratio of myoglobin over fatty acid-binding protein. Circulation 1995, 92:2848-2854.
23. Brueckmann M., Wolpert C., Bertsch T., Sueselbeck T., Liebetrau C., Kaden J.J., Huhle G., Neumaier M., Borggrefe M., Haase K.K. Markers of myocardial damage, tissue healing, and inflammation after radiofrequency catheter ablation of atrial tachyarrythmias. J Cardiovasc Electrophysiol 2004, 15:686-691.
24. Haegeli L.M., Kotschet E., Byrne J., Adam D.C., Lockwood E.E., Leather R.A., Sterns L.D., Novak P.G. Cardiac injury after percutaneous catheter ablation for atrial fibrillation. Europace 2008, 10:273-275.
25. Madrid A.H., del Rey J.M., Rubi J., Ortega J., Rebollo Gonzalez J.M., Seara J.G., Ripoll E., Moro C. Biochemical markers and cardiac troponin I release after radiofrequency catheter ablation: approach to size of necrosis. Am Heart J 1998, 136:948-955.
26. del Rey J.M., Madrid A.H., Valiño J.M., Rubí J., Mercader J., Moro C., Ripoll E. Cardiac troponin I and minor cardiac damage: biochemical markers in a clinical model of myocardial lesions. Clin Chem 1998, 44:2270-2276.
27. Pudil R., Parízek P., Tichỳ M., Haman L., Horáková L., Ulrychová M., Vojácek J., Palicka V. Use of the biochip microarray system in detection of myocardial injury caused by radiofrequency catheter ablation. Clin Chem Lab Med 2008, 46:1726-1728.
28. Hirose H., Kato K., Suzuki O., Yoshida T., Oguri M., Yajima K., Hibino T., Yokoi K. Diagnostic accuracy of cardiac markers for myocardial damage after radiofrequency catheter ablation. J Interv Card Electrophysiol 2006, 16:169-174.
29. Khan H.H., Maisel W.H., Ho C., Suzuki M., Soejima K., Solomon S., Stevenson W.G. Effect of radiofrequency catheter ablation of ventricular tachycardia on left ventricular function in patients with prior myocardial infarction. J Interv Card Electrophysiol 2002, 7:243-247.
30. Eksik A., Gorgogulu S., Eren M., Akyol A., Erlindner I., Oguz E., Gurkan K., Ulufer T., Tezel T. Sequential evaluation of left ventricular systolic and diastolic function after radiofrequency catheter ablation. Jpn Heart J 2004, 45:429-440.
31. Sassone B., Leone O., Martinelli G.N., Di Pasquale G. Acute myocardial infarction after radiofrequency catheter ablation of typical atrial flutter: histopathological findings and etiopathogenetic hypothesis. Ital Heart J 2004, 5:403-407.